Epidermal growth factor is a critical regulator of the cytokine IL‐33 in intestinal epithelial cells

Abstract

Our results suggest that EGF is a key growth factor that increased IL-33 production and ST2 receptor expression during intestinal inflammation and carcinogenesis. The EGF/IL-33/ST2 axis represents a novel therapeutic target in colon cancer.